Showing 1 - 10 of 496
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10003480016
Persistent link: https://www.econbiz.de/10003654977
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10012776880
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10012465529
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10005830628
Persistent link: https://www.econbiz.de/10000420226
Persistent link: https://www.econbiz.de/10002774930
Persistent link: https://www.econbiz.de/10001860150
Persistent link: https://www.econbiz.de/10005293365
Public provision of health care, as under Medicare and Medicaid, traditionally “privatized” major production decisions. Providers of care, largely private physicians and hospitals (but also public hospitals), made significant decisions about public beneficiaries' access to care, the quality...
Persistent link: https://www.econbiz.de/10008644711